In AD samples, neurons showed downregulation of GABA receptor (GABRA2, GABRB1), glutamate receptor (GRIA2, GRID2), and neurexin (NRXN1, NRXN3) genes, consistent with the loss of synapses seen in AD. This evidence concerns the gene GABRA2 and Alzheimer disease.